pharma news

News

CARSgen bags world-first approval for solid tumour CAR-T

CARSgen Therapeutics has claimed approval in China for gastric cancer therapy satri-cel, the first CAR-T to be cleared for a solid tumour.

News

AbbVie climbs post-Allergan M&A peak with Apogee buy

AbbVie has announced its biggest acquisition since the $63 billion merger with Allergan, buying Apogee and its 'mega-blockbuster' immunology pipeline.

News

Boehringer advances duo for aggressive cancers into phase 3

Boehringer Ingelheim steps up its push into oncology with phase 3 trials for pathfinder product Hernexeos and obrixtamig in hard-to-treat cancers.

News

Insilico and SK Bio forge $2.5bn AI neuroimmunity alliance

Insilico Medicine has teamed up with SK Biopharmaceuticals on a wide-ranging, $2.5bn partnership to use AI to find neuroimmune drug candidates.

News

Sanofi names ex-Roche exec Fontoura as R&D chief

Paulo Fontoura, currently chief medical officer of Xaira Therapeutics, will replace Houmab Ashrafian as Sanofi's R&D head on 1st September.

News

US launches probe of German 'underpayment' for medicines

A Section 301 probe by the US Trade Representative into Germany's medicine pricing and reimbursement policies raises the threat of punitive tariffs.

CARSgen bags world-first approval for solid tumour CAR-T

AbbVie climbs post-Allergan M&A peak with Apogee buy

Boehringer advances duo for aggressive cancers into phase 3

Insilico and SK Bio forge $2.5bn AI neuroimmunity alliance

Sanofi names ex-Roche exec Fontoura as R&D chief

US launches probe of German 'underpayment' for medicines

Repligen builds in cell therapy with $1.5bn BioLife takeover

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks